Toviaz (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Toviaz drug offered from Pfizer Laboratories Div Pfizer Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | fesoterodine fumarate |
| SUBSTANCE NAME: | FESOTERODINE FUMARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-10-31 |
| END MARKETING DATE: | 0000-00-00 |
Toviaz HUMAN PRESCRIPTION DRUG Details:
| Item Description | Toviaz from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/1) |
| START MARKETING DATE: | 2008-10-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0242_205f60a0-ffa1-4802-93d5-f4df5d6477bb |
| PRODUCT NDC: | 0069-0242 |
| APPLICATION NUMBER: | NDA022030 |
Other FESOTERODINE FUMARATE Pharmaceutical Manufacturers / Labelers:
